Your shopping cart is empty

Subscriber login

REGISTER FOR FREE EZINES

Advanced Search

Home
Books
Conferences
DVDs
Newsletters
Form 483s
Pharma Quality Advisor
Webinar Training Pass
White Papers
Advertising/Sponsorships
About Us

E-Zines

Check out our free and informative ezines and sign up now

Home > Newsletters > Clinical Trials Advisor > GSK Plans to Open Patient-Level Trial Data to Outside Researchers

Clinical Trials Advisor

Oct. 25, 2012 | Vol. 17 No. 21

GSK Plans to Open Patient-Level Trial Data to Outside Researchers

GlaxoSmithKline will soon give researchers access to detailed anonymized patient-level clinical data for approved drugs and dropped investigational products.

This article is viewable by subscribers only. To view this article, please select an option below.

Subscribe
Print This Page
RSS
Free Trial
Archives
Sample PDF

Related Articles

Comings & Goings Survey: More Payer Appeal Expected for Devices in Future Survey Gives Tips for Devicemakers to Reduce Battery Problems Actavis Woos Warner Chilcott; Eyes Brand Access, Tax Perks

Home
Advertising/Sponsorships
About Us
Contact Us
Site Map
Privacy Policy

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA.
Phone (703) 538-7600 - Fax (703) 538-7676 - Toll free (888) 838-5578.

ePublishing :: CMS, Hosting & Web Development | © Copyright by FDAnews

All rights reserved. Do not duplicate or redistribute in any form.